Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Current Liabilities (2019 - 2025)

Volitionrx's Total Current Liabilities history spans 9 years, with the latest figure at $12.2 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 56.99% year-over-year to $12.2 million; the TTM value through Dec 2025 reached $12.2 million, up 56.99%, while the annual FY2025 figure was $12.2 million, 56.99% up from the prior year.
  • Total Current Liabilities reached $12.2 million in Q4 2025 per VNRX's latest filing, up from $11.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $31.5 million in Q1 2024 to a low of $5.4 million in Q2 2021.
  • Average Total Current Liabilities over 5 years is $15.3 million, with a median of $17.0 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: surged 221.42% in 2022, then tumbled 73.73% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $6.5 million in 2021, then skyrocketed by 166.83% to $17.4 million in 2022, then plummeted by 48.56% to $8.9 million in 2023, then dropped by 12.89% to $7.8 million in 2024, then skyrocketed by 56.99% to $12.2 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Total Current Liabilities are $12.2 million (Q4 2025), $11.4 million (Q3 2025), and $9.2 million (Q2 2025).